Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors One Year After Infection

January 2024 in “ Journal of Primary Care & Community Health ”

Adam F. Aldhawyan, Mohammed A. BuSaad, Bothayna A. Alamri, Mohammed I. Alsaihati, Bader S. Alanazi, Rayyanah Alanazi, Ahmed Bahamdan

TLDR Long COVID symptoms vary and are influenced by personal and health factors.

The study investigates the predictors of persistent long COVID symptoms and their severity in survivors 1 year after infection. It finds that the severity of long COVID symptoms varies among patients and is influenced by sociodemographic and clinical factors. Understanding these factors is crucial for optimizing management strategies and improving patient outcomes.

View this study on journals.sagepub.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Epidemiology of Post-COVID Conditions Beyond 1 Year: A Cross-Sectional Study

19 citations , February 2023 in “Public Health”

Over 25% of COVID-19 patients had symptoms lasting more than a year.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

1250 citations , August 2021 in “Scientific Reports”

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

research Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19

737 citations , August 2020 in “Journal of Infection”

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

research Telogen Effluvium: A Comprehensive Review

56 citations , August 2019 in “Clinical, Cosmetic and Investigational Dermatology”

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.